Equity8888

Equity8888
Send Message
View as an RSS Feed
  • Realty Income's Inherent Advantage  [View article]
    Hi,

    For the cost of equity, why do you not use Total Return which would be about 4.5% (div) + 4.5% (div growth) = 9%?

    Thanks
    Nov 9, 2015. 05:40 AM | Likes Like |Link to Comment
  • Tantamount To A “I Told You So”, The Natural Gas Bubble Is Still Popping “Look Out Below!”  [View instapost]
    i think this pull back is short, should see above $4 again.
    Jun 1, 2013. 06:45 AM | Likes Like |Link to Comment
  • Spectrum Pharma: Zevalin Has Blockbuster Potential  [View article]
    6 Moves Ahead,

    I am sorry for you that you had to sell ur 100,000/1000 shares...

    at $4.59, there was no sale of 100,000 shares, so thx for ur nonsense. This further shows ur ignorance.

    We shall see tomorrow, SPPI will present something. They already know the result of 2 months of ZEVALIN SALES.
    Oct 26, 2009. 05:56 PM | 1 Like Like |Link to Comment
  • Spectrum Pharma: Zevalin Has Blockbuster Potential  [View article]
    hi, this is indeed a very good article that you have written.

    I have always thought that ZEVALIN was SPPI greatest hope. FUSILEV is just a side product if successful would increase the value of SPPI, I didnt expect FUSILEV rejection to affect the price.

    I really hope that RAJ would give guidance on ZEVALIN. Perhaps an estimate of $100mln sales for 2010 is good. It looks like the CME reimbursement will succeed since there has been no uproar about it since August. So they should make it official really soon.

    Consolidation therapy is indeed good for complete remission, and I really think ZEVALIN could become a blockbuster drug. With the 40 men sales team, RAJ is actually doing a great job now.

    BIOCOM conference at 930am, 27OCTOBER, this should release something.

    And lastly, the FIBONACCI 61.8% retracement level is at $4.15, so expect price to rebound from there, this projects a profit taking level at $16.80, which is a FIBONACCI number, hopefully the magic of FIBONACCI will work with SPPI.

    It worked with MGM, LVS.
    Oct 25, 2009. 11:50 AM | 4 Likes Like |Link to Comment
  • Spectrum Pharma: Zevalin Has Blockbuster Potential  [View article]
    Just as I thought, it is ZEVALIN that would bring SPPI value up. Fusilev is just another good drug, but ZEVALIN is the one with blockbuster potential.

    I hope to see the ZEVALIN sales increase to $5mln for 3rd Quarter, and I will fully invest in SPPI.

    Nice work, I know we are sadden by the dismal performance of SPPI, but ZEVALIN is full of hope. And EOQUIN as well. Asian partner coming up?

    And what do you think about the BIOCOM conference that SPPI is going to present in on 27th October, 930am. By any chance will they reveal the demand of ZEVALIN?
    Oct 24, 2009. 09:04 AM | 2 Likes Like |Link to Comment
  • Spectrum Pharmaceuticals: Undervalued and (Now) Oversold  [View article]
    Hi Justin,

    with the disapproval of FUSILEV, what is the current ideal valuation of SPPI?

    Zevalin sales can only be worked out in 3 months, so what is left for now till then? Any expected upside?
    Oct 12, 2009. 09:41 PM | Likes Like |Link to Comment
COMMENTS STATS
6 Comments
7 Likes